Who's Affected?
- 60% of contact lens wearers3
- 57% of diabetics5
52% of cataract patients7
Plus, in a separate study, 72.5% of patients presenting for refractive surgery evaluation had meibomian gland atrophy (indicative of MGD).8
- 86.8% of perimenopausal women4
- 80% of glaucoma patients6